Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
YAP (Yes-associated protein) is a transcription co-activator in the Hippo tumour suppressor pathway and controls cell growth, tissue homeostasis and organ size. YAP is inhibited by the kinase Lats, which phosphorylates YAP to induce its cytoplasmic localization and proteasomal degradation. YAP induces gene expression by binding to the TEAD family transcription factors. Dysregulation of the Hippo-YAP pathway is frequently observed in human cancers. Here we show that cellular energy stress induces YAP phosphorylation, in part due to AMPK-dependent Lats activation, thereby inhibiting YAP activity. Moreover, AMPK directly phosphorylates YAP Ser 94, a residue essential for the interaction with TEAD, thus disrupting the YAP-TEAD interaction. AMPK-induced YAP inhibition can suppress oncogenic transformation of Lats-null cells with high YAP activity. Our study establishes a molecular mechanism and functional significance of AMPK in linking cellular energy status to the Hippo-YAP pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the direct phosphorylation of YAP on Ser61/94, which is key for the interaction between Yap and Teads (100, 145).”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [100]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Both glucose starvation (36, 100, 145) and AMPK activators (26, 100, 145) inhibit Yap in different cell types.”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [100]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Endurance exercise-associated signals linked to YAP/TAZ”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as Mo et al Nature Cell Biol (2015)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“…the AMPK-DN increased reporter activity, consistent with the notion that AMPK-DN interferes with endogenous AMPK function in a dominant-negative fashion ‥ Metformin, a widely prescribed drug for type II diabetes 35 , activates AMPK, inhibits cell growth and reduces tumor incidence 36, 37 .”
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227
Self-citationRole of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Self-citationZhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
Self-citationTEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Self-citationMetformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
Cited by
Items 101–200 of 593
Ou, C., Sun, Z., Li, X., Li, X., Ren, W., Qin, Z., Zhang, X., Yuan, W., Wang, J., Yu, W., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.011 · Cited by 116
Hippo signalling during development
Davis, J. R., & Tapon, N. (2019) · Development · doi:10.1242/dev.167106 · Cited by 110
Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer
Mohajan, S., Jaiswal, P. K., Vatanmakarian, M., Yousefi, H., Saikolappan, S., Alahari, S. K., Koul, S., & Koul, H. K. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.03.006 · Cited by 116
The Roles of NDR Protein Kinases in Hippo Signalling
Hergovich, A. (2016) · Genes · doi:10.3390/genes7050021 · Cited by 105
The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin
Rognoni, E., & Walko, G. (2019) · Cells · doi:10.3390/cells8050411 · Cited by 112
Heat stress activates YAP/TAZ to induce the heat shock transcriptome
Luo, M., Meng, Z., Moroishi, T., Lin, K. C., Shen, G., Mo, F., Shao, B., Wei, X., Zhang, P., Wei, Y., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-00602-9 · Cited by 112
Self-citationHuang, H., Zhang, W., Pan, Y., Gao, Y., Deng, L., Li, F., Li, F., Ma, X., Hou, S., Xu, J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0449 · Cited by 111
Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies
Kim, M. H., & Kim, J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2412-x · Cited by 110
A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations
Yamaguchi, H., & Taouk, G. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00928 · Cited by 110
Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells
Wu, Y., Zheng, Q., Li, Y., Wang, G., Gao, S., Zhang, X., Yan, X., Zhang, X., Xie, J., Wang, Y., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1346-1 · Cited by 107
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Cao, R. Y., Tian, H., Zhang, Y., Liu, G., Xu, H., Rao, G., Tian, Y., & Fu, X. (2023) · MedComm · doi:10.1002/mco2.283 · Cited by 108
Multifaceted regulation and functions of YAP/TAZ in tumors (Review)
Liu, H., Du, S., Lei, T., Wang, H., He, X., Tong, R., & Wang, Y. (2018) · Oncology Reports · doi:10.3892/or.2018.6423 · Cited by 105
Wang, X., Ha, T., Liu, L., Hu, Y., Kao, R. L., Kalbfleisch, J. H., Williams, D. L., & Li, C. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-017-0036-9 · Cited by 105
STRIPAK complexes in cell signaling and cancer
Shi, Z., Jiao, S., & Zhou, Z. (2016) · Oncogene · doi:10.1038/onc.2016.9 · Cited by 103
Targeting FOXM1 condensates reduces breast tumour growth and metastasis
Xie, F., Zhou, X., Ran, Y., Li, R., Zou, J., Wan, S., Su, P., Meng, X., Yan, H., Lu, H., et al. (2025) · Nature · doi:10.1038/s41586-024-08421-w · Cited by 102
The Hippo Pathway in Prostate Cancer
Salem, O., & Hansen, C. G. (2019) · Cells · doi:10.3390/cells8040370 · Cited by 102
Self-citationKobayashi, Y., Lim, S., & Yamaguchi, H. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.11.011 · Cited by 100
Evidence of cancer‐promoting roles for AMPK and related kinases
Monteverde, T., Muthalagu, N., Port, J., & Murphy, D. J. (2015) · FEBS Journal · doi:10.1111/febs.13534 · Cited by 100
YAP and TAZ Take Center Stage in Cancer
Zhang, K., Qi, H.-X., Hu, Z., Chang, Y., Shi, Z., Han, X., Han, Y., Zhang, R., Zhang, Z., Chen, T., et al. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b01014 · Cited by 99
Hippo signaling pathway and respiratory diseases
Tang, W., Li, M., Yangzhong, X., Zhang, X., Zu, A., Hou, Y., Li, L., & Sun, S. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01020-6 · Cited by 90
Hippo and TGF-β interplay in the lung field
Saito, A., & Nagase, T. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00238.2015 · Cited by 91
Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy
Juan, W., & Hong, W. (2016) · Genes · doi:10.3390/genes7090055 · Cited by 85
The Hippo signaling pathway provides novel anti-cancer drug targets
Bae, J. S., Kim, S. M., & Lee, H. (2016) · Oncotarget · doi:10.18632/oncotarget.14306 · Cited by 96
Self-citationA feed forward loop enforces YAP/TAZ signaling during tumorigenesis
Gill, M. K., Christova, T., Zhang, Y. Y., Gregorieff, A., Zhang, L., Narimatsu, M., Song, S., Xiong, S., Couzens, A. L., Tong, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05939-2 · Cited by 95
TNFα-YAP/p65-HK2 axis mediates breast cancer cell migration
Gao, Y., Yang, Y., Yuan, F., Huang, J., Xu, W., Mao, B., Yuan, Z., & Bi, W. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.83 · Cited by 96
Furth, N., Aylon, Y., & Oren, M. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.163 · Cited by 95
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells
Elster, D., Tollot, M., Schlegelmilch, K., Ori, A., Rosenwald, A., Sahai, E., & von Eyss, B. (2018) · Nature Communications · doi:10.1038/s41467-018-05370-7 · Cited by 86
Dissecting the role of AMP-activated protein kinase in human diseases
Li, J., Zhong, L., Wang, F., & Zhu, H. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.12.003 · Cited by 94
The Hippo Pathway Regulates Caveolae Expression and Mediates Flow Response via Caveolae
Rausch, V., Bostrom, J. R., Park, J., Bravo, I. R., Feng, Y., Hay, D. C., Link, B. A., & Hansen, C. G. (2018) · Current Biology · doi:10.1016/j.cub.2018.11.066 · Cited by 94
Self-citationKRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops
Eibl, G., & Rozengurt, E. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.007 · Cited by 85
Li, L., Liu, T., Li, Y., Wu, C., Luo, K., Yin, Y., Chen, Y., Nowsheen, S., Wu, J., Lou, Z., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0134-2 · Cited by 92
A review of signal pathway induced by virulent protein CagA of Helicobacter pylori
Wang, H., Zhao, M., Shi, F., Zheng, S., Xiong, L., & Zheng, L. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1062803 · Cited by 91
Watanabe, Y., Miyasaka, K. Y., Kubo, A., Kida, Y. S., Nakagawa, O., Hirate, Y., Sasaki, H., & Ogura, T. (2017) · Scientific Reports · doi:10.1038/srep46135 · Cited by 90
Current Understandings of Core Pathways for the Activation of Mammalian Primordial Follicles
Zhao, Y., Feng, H., Zhang, Y., Zhang, J. V., Wang, X., Liu, D., Wang, T., Li, R., Ng, E. H. Y., Yeung, W. S. B., et al. (2021) · Cells · doi:10.3390/cells10061491 · Cited by 89
Mechanotransduction in the pathogenesis of non-alcoholic fatty liver disease
Mitten, E. K., & Baffy, G. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.028 · Cited by 79
Szulzewsky, F., Arora, S., Hoellerbauer, P., King, C., Nathan, E., Chan, M., Cimino, P. J., Ozawa, T., Kawauchi, D., Pajtler, K. W., et al. (2020) · Genes & Development · doi:10.1101/gad.338681.120 · Cited by 89
Atheroprotective laminar flow inhibits Hippo pathway effector YAP in endothelial cells
Xu, S., Koroleva, M., Yin, M., & Jin, Z. G. (2016) · Translational Research · doi:10.1016/j.trsl.2016.05.003 · Cited by 82
The history and regulatory mechanism of the Hippo pathway
Kim, W., & Jho, E. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.3.022 · Cited by 87
Yin, L., Li, W., Xu, A., Shi, H., Wang, K., Yang, H., Wang, R., & Peng, B. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.12.005 · Cited by 84
Regulation of the Hippo pathway in cancer biology
Moon, S., Park, S. Y., & Park, H. W. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2804-1 · Cited by 83
Self-citationSnaebjornsson, M. T., & Schulze, A. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0065-6 · Cited by 83
Kawashima, I., & Kawamura, K. (2017) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2017.1411990 · Cited by 82
The emerging role of Hippo signaling in neurodegeneration
Sahu, M. R., & Mondal, A. C. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24551 · Cited by 78
Jiang, Z., Chen, X., Chen, K., Sun, L., Gao, L., Zhou, C., Meng, L., Duan, W., Wang, Z., Ma, Q., et al. (2016) · Nutrients · doi:10.3390/nu8100546 · Cited by 79
Hepatic Hippo signaling inhibits development of hepatocellular carcinoma
Liu, Y., Wang, X., & Yang, Y. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0178 · Cited by 78
Dai, X.-Y., Zhuang, L.-H., Wang, D.-D., Zhou, T.-Y., Chang, L.-L., Gai, R.-H., Zhu, D.-F., Yang, B., Zhu, H., & He, Q.-J. (2016) · Oncotarget · doi:10.18632/oncotarget.6903 · Cited by 72
Dishevelled has a YAP nuclear export function in a tumor suppressor context-dependent manner
Lee, Y., Kim, N. H., Cho, E. S., Yang, J. H., Cha, Y. H., Kang, H. E., Yun, J. S., Cho, S. B., Lee, S.-H., Paclíková, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04757-w · Cited by 76
Self-citationEnergy expenditure during cell spreading influences the cellular response to matrix stiffness
Xie, J., Bao, M., Hu, X., Koopman, W. J. H., & Huck, W. T. S. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120494 · Cited by 76
A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer
Khan, A. S., & Frigo, D. E. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2016.272 · Cited by 72
Upstairs, downstairs: spatial regulation of Hippo signalling
Fulford, A. D., Tapon, N., & Ribeiro, P. S. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.10.006 · Cited by 74
The Ambivalent Function of YAP in Apoptosis and Cancer
Zhang, X., Abdelrahman, A., Vollmar, B., & Zechner, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123770 · Cited by 74
Liu, X., Ma, F., Liu, C., Zhu, K., Li, W., Xu, Y., Li, G., Niu, Z., Liu, J., Du, C., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-019-2194-9 · Cited by 73
DNA-binding mechanism of the Hippo pathway transcription factor TEAD4
Shi, Z., He, F., Chen, M., Hua, L., Wang, W., Jiao, S., & Zhou, Z. (2017) · Oncogene · doi:10.1038/onc.2017.24 · Cited by 73
Implications of Nonphysiological Ovarian Primordial Follicle Activation for Fertility Preservation
Grosbois, J., Devos, M., & Demeestere, I. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa020 · Cited by 73
Zhu, D., Liang, H., Du, Z., Liu, Q., Li, G., Zhang, W., Wu, D., Zhou, X., Song, Y., & Cao, Y. (2024) · Research · doi:10.34133/research.0350 · Cited by 72
Gu, Y. J., Chen, Y., Wei, L., Wu, S., Shen, K., Liu, C., Dong, Y., Yang, Z., Zhang, Y., Zhang, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26967-5 · Cited by 70
MST4 kinase suppresses gastric tumorigenesis by limiting YAP activation via a non-canonical pathway
An, L., Nie, P., Chen, M., Tang, Y., Zhang, H., Guan, J., Cao, Z., Hou, C., Wang, W., Zhao, Y., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191817 · Cited by 70
New Insights into YAP/TAZ-TEAD-Mediated Gene Regulation and Biological Processes in Cancer
Zhao, Y., Sheldon, M., Sun, Y., & Ma, L. (2023) · Cancers · doi:10.3390/cancers15235497 · Cited by 68
Jang, J.-W., Kim, M.-K., Lee, Y.-S., Lee, J., Kim, D.-M., Song, S., Lee, J.-Y., Choi, B.-Y., Min, B., Chi, X.-Z., et al. (2016) · Oncogene · doi:10.1038/onc.2016.266 · Cited by 66
Tissue and cellular rigidity and mechanosensitive signaling activation in Alexander disease
Wang, L., Xia, J., Li, J., Hagemann, T. L., Jones, J. R., Fraenkel, E., Weitz, D. A., Zhang, S.-C., Messing, A., & Feany, M. B. (2018) · Nature Communications · doi:10.1038/s41467-018-04269-7 · Cited by 55
Dysregulation of the Hippo pathway signaling in aging and cancer
Yeung, Y. T., Guerrero‐Castilla, A., Cano, M., Muñoz, M. F., Ayala, A., & Argüelles, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.018 · Cited by 65
AMPK at the interface of nutrient sensing, metabolic flux and energy homeostasis
Smith, T. K. T., Townsend, L. K., Smiles, W. J., Oakhill, J. S., Fullerton, M. D., & Steinberg, G. R. (2026) · Nature Metabolism · doi:10.1038/s42255-025-01442-3 · Cited by 65
Claude‐Taupin, A., Isnard, P., Bagattin, A., Kuperwasser, N., Roccio, F., Ruscica, B., Goudin, N., Garfa‐Traoré, M., Regnier, A., Turinsky, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43775-1 · Cited by 63
Gailite, I., Aerne, B. L., & Tapon, N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505512112 · Cited by 55
Yu, Y., Su, X., Qin, Q., Hou, Y., Zhang, X., Zhang, H., Jia, M., & Chen, Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105009 · Cited by 63
Metabolic and Mechanical Cues Regulating Pluripotent Stem Cell Fate
Perestrelo, T., Correia, M., Ramalho‐Santos, J., & Wirtz, D. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.09.005 · Cited by 62
Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies
Rozengurt, E., & Eibl, G. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02499-y · Cited by 64
Ma, K., Xu, Q., Wang, S., Zhang, W., Liu, M., Liang, S., Zhu, H., & Xu, N. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.045 · Cited by 62
Garcia, G., Paul, S., Beshara, S., Ramanujan, V. K., Ramaiah, A., Nielsen‐Saines, K., Li, M. M. H., French, S. W., Morizono, K., Kumar, A., et al. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.12.005 · Cited by 62
Transcriptional co-activators YAP/TAZ: Potential therapeutic targets for metastatic breast cancer
Zhao, W., Wang, M., Cai, M., Zhang, C.-H., Qiu, Y., Wang, X., Zhang, T., Zhou, H., Wang, J., Zhao, W., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110956 · Cited by 62
Neuronal Hippo signaling: From development to diseases
Sahu, M. R., & Mondal, A. C. (2020) · Developmental Neurobiology · doi:10.1002/dneu.22796 · Cited by 62
LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism
He, X., Xiao, F., Qu, L., Wang, X., Jiang, L., Sang, L., Shi, C., Lin, S., Yang, J., Yang, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37871-5 · Cited by 61
Vaidyanathan, S., Salmi, T. M., Sathiqu, R. M., McConville, M. J., Cox, A. G., & Brown, K. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.02.004 · Cited by 60
The Hippo pathway: Organ size control and beyond
Guo, P., Wan, S., & Guan, K. (2024) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100031 · Cited by 60
Self-citationRole of Angiomotin‐like 2 mono‐ubiquitination on YAP inhibition
Kim, M., Kim, M., Park, S., Lee, C., & Lim, D. (2015) · EMBO Reports · doi:10.15252/embr.201540809 · Cited by 60
Self-citationIdentification of the kinase STK25 as an upstream activator of LATS signaling
Lim, S., Hermance, N. M., Mudianto, T., Mustaly, H. M., Mauricio, I. P. M., Vittoria, M. A., Quinton, R. J., Howell, B. W., Cornils, H., Manning, A. L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09597-w · Cited by 60
MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis
Kim, J.-Y., Kwon, H., Shin, Y. K., Song, G., Lee, T. B., Kim, Y., Jeong, W., Lee, U., Zhang, X., Nam, G., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917969117 · Cited by 60
Self-citationStructural and Functional Overview of TEAD4 in Cancer Biology
Chen, M., Huang, B., Zhu, L., Chen, K., Liu, M., & Zhong, C. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s266649 · Cited by 60
Liu, J., Li, J., Chen, H., Wang, R., Li, P., Miao, Y., & Liu, P. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15241 · Cited by 59
YAP in pancreatic cancer: oncogenic role and therapeutic strategy
Mao, W., Mai, J., Peng, H., Wan, J., & Sun, T. (2020) · Theranostics · doi:10.7150/thno.53438 · Cited by 59
The hippo pathway: A master regulator of liver metabolism, regeneration, and disease
Nguyen‐Lefebvre, A. T., Selzner, N., Wrana, J. L., & Bhat, M. (2021) · The FASEB Journal · doi:10.1096/fj.202002284rr · Cited by 58
An Amorphous Peri‐Implant Ligament with Combined Osteointegration and Energy‐Dissipation
Hou, J., Xiao, Z., Liu, Z., Zhao, H., Zhu, Y., Guo, L., Zhang, Z., Ritchie, R. O., Wei, Y. Q., & Deng, X. (2021) · Advanced Materials · doi:10.1002/adma.202103727 · Cited by 58
Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential
Lv, L., & Zhou, X. (2023) · MedComm · doi:10.1002/mco2.375 · Cited by 58
Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
Sekido, Y. (2018) · Cancers · doi:10.3390/cancers10040090 · Cited by 58
Hippo-Independent Regulation of Yki/Yap/Taz: A Non-canonical View
Cho, Y. S., & Jiang, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.658481 · Cited by 57
Sileo, P., Simonin, C., Melnyk, P., Chartier‐Harlin, M., & Cotelle, P. (2022) · Cells · doi:10.3390/cells11223631 · Cited by 57
Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis
Chen, X., Stauffer, S., Chen, Y., & Dong, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.722751 · Cited by 57
Zhou, X., & Lei, Q. (2016) · Protein & Cell · doi:10.1007/s13238-016-0288-z · Cited by 57
Regulation of Tissue Growth by the Mammalian Hippo Signaling Pathway
Watt, K. I., Harvey, K. F., & Gregorevic, P. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00942 · Cited by 57
TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression
Hwang, J.-H., Kim, A. R., Kim, K. M., Park, J. I., Oh, H. T., Moon, S. A., Byun, M. R., Jeong, H., Kim, H. K., Yaffe, M. B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08287-x · Cited by 58
Targeting the Hippo pathway in heart repair
Meng, F., Xie, B., & Martin, J. F. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab291 · Cited by 56
Metformin: review of epidemiology and mechanisms of action in pancreatic cancer
Eibl, G., & Rozengurt, E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09977-z · Cited by 55
Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness
Rachedi, N., Tang, Y., Tai, Y.-Y., Zhao, J., Chauvet, C., Grynblat, J., Akoumia, K. K. F., Estephan, L. E., Torrino, S., Sbai, C., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.010 · Cited by 54
Wang, Y., Wang, Q., Tao, S., Li, H., Zhang, X., Xia, Y., Wang, Y., Yang, C. Z., & Sui, C. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217199 · Cited by 54
Hippo‐Yap/Taz signaling: Complex network interactions and impact in epithelial cell behavior
van Soldt, B. J., & Cardoso, W. V. (2019) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.371 · Cited by 54
Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck
Santos-de-Frutos, K., Segrelles, C., & Lorz, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122131 · Cited by 53
Mechanical force regulation of YAP by F-actin and GPCR revealed by super-resolution imaging
Gao, J., He, L., Zhou, L., Jing, Y., Wang, F., Shi, Y. C., Cai, M., Sun, J., Xu, H., Jiang, J., et al. (2020) · Nanoscale · doi:10.1039/c9nr09452k · Cited by 53
The HIPPO pathway in gynecological malignancies.
Wang, D., He, J., Dong, J., Meyer, T. F., & Xu, T. (2020) · PubMed Central · Cited by 53
Xiang, Y.-C., Peng, P., Liu, X., Jin, X., Shen, J. M., Zhang, T., Zhang, L., Wan, F., Ren, Y., Yu, Q., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00755-9 · Cited by 53
O-GlcNAcylation regulation of cellular signaling in cancer
Ciraku, L., Esquea, E. M., & Reginato, M. J. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110201 · Cited by 52
Metadata
- Authors
- Mo, J.-S., Meng, Z., Kim, Y. C., Park, H. W., Hansen, C. G., Kim, S., Lim, D.-S., & Guan, K.-L.
- Affiliations
- University of California San Diego (US)
- Veterans Medical Research Foundation of San Diego (US)
- Korea Advanced Institute of Science and Technology (KR)
- Corresponding author
- Guan, Kun-Liang
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2015-03-09
- Volume
- 17
- Issue
- 4
- Pages
- 500-510
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC4380774
- OpenAlex
- W1999661963
- Cited by
- 557
- References
- 51
- Citations by year
- 2026: 39 · 2025: 42 · 2024: 54 · 2023: 54 · 2022: 55 · 2021: 48 · 2020: 72 · 2019: 43 · 2018: 53 · 2017: 39 · 2016: 38 · 2015: 20
- FWCI
- 26.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Eye Institute (R01EY022611, EY022611)
- National Cancer Institute (CA 23100, CA132809, R01CA132809, P30CA023100)
- National Institute of Dental and Craniofacial Research (DE015964, R01DE015964)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- YAP, Hippo signaling pathway, AMPK, LATS kinase, YAP phosphorylation, TEAD transcription factors, oncogenic transformation, tumor suppression, glucose homeostasis, starvation
- MeSH terms
- Hippo Signaling Pathway, YAP-Signaling Proteins, TEA Domain Transcription Factors, Acyltransferases, Animals, Cell Line, Cell Transformation, Neoplastic, Cytoplasm, DNA-Binding Proteins, Energy Metabolism, Enzyme Activation, HeLa Cells, Humans, Mice, Nude, Nuclear Proteins, Phosphoproteins, Phosphorylation, Transcription Factors, Signal Transduction, 3T3 Cells, Protein Serine-Threonine Kinases, RNA Interference, RNA, Small Interfering, Adaptor Proteins, Signal Transducing, Mice, AMP-Activated Protein Kinases, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.